Academic Journals Database
Disseminating quality controlled scientific knowledge

Expression of leptin and its receptor in female breast cancer in relation with selected apoptotic markers.

ADD TO MY LIST
 
Author(s): Mariusz Koda | Mariola Sulkowska | Luiza Kanczuga-Koda | Katarzyna Jarzabek | Stanislaw Sulkowski

Journal: Folia Histochemica et Cytobiologica
ISSN 0239-8508

Volume: 45;
Issue: Suppl 1;
Start page: 187;
Date: 2008;
Original page

ABSTRACT
Leptin and its receptor may be engaged in pathogenesis of breast cancer among various human tumors. In vitro investigations showed leptin-mediated escalation of estrogen synthesis and boosted activity of estrogen receptor ERalpha. Furthermore, leptin induced growth of malignant cells, counteracted apoptosis and stimulated cell migration as well as overexpression of angiogenic factors and degrading enzymes that split network of intercellular matrix. On the other side, leptin has been reported to favor apoptosis, lately. Proapoptotic effect of leptin action was revealed in interstitial cells of bone marrow and adipocytes. Our past reports provide evidences for overexpression of leptin and its receptor in breast cancer in comparison with benign mammary lesions. In current study we aimed at assessment of eventual relationships between leptin, leptin receptor and selected protein regulators of apoptosis in breast cancer. We applied immunohistochemistry for leptin, leptin receptor, anti-apoptotic Bcl-2 and Bcl-xL as well as pro-apoptotic Bak and Bax expression assessment in 106 cases of human breast cancers. The immunoreaction was graded and statistically evaluated. Expression of leptin was positively correlated with Bcl-xL, Bak and Bax (p
Save time & money - Smart Internet Solutions      Why do you need a reservation system?